UNSPSC 51282206: Cefotetan disodium

This classification denotes a cephalosporin antibiotic with the molecular formula C17H15N7O8S4.2Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0GXP746VXB, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1h-tetrazol-5-yl)thio)methyl)-8-oxo-, disodium salt, (6r-(6alpha,7alpha))- but more generally known as cefotetan disodium, which bears US NIH Compound Identifier 53024.

UNSPSC 51282206 Cefotetan disodium is a Commodity code covering a specific third-generation cephalosporin antibiotic, but the recent state and local opportunities tagged under it do not reflect pharmaceutical procurement for this drug. The two records in the dataset show completed or closed solicitations for unrelated pharmaceutical products—doxycycline and ciprofloxacin tablets through an Illinois Department of Public Health piggyback arrangement, and naloxone with drug deactivation systems through Seminole County, Florida—neither of which align with cefotetan disodium procurement. State and local health departments, public health agencies, and county health systems are the typical issuing bodies for pharmaceutical commodity codes in this range, but the available records offer no current signal of active demand for cefotetan disodium specifically.

Geographic activity is limited to Illinois and Florida in the available records, though both opportunities represent completed awards or expired solicitations rather than open buy windows. The Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, under an Invitation for Bid process, with an initial 12-month term and two renewal options. Seminole County's naloxone and drug deactivation systems IFB (60459723LAS) closed on July 26, 2023, predating the current window by over three years. The code shows little relevant recent procurement activity for cefotetan disodium, and the mismatch between the code's nominal scope and the products actually being bought suggests either tagging inconsistency or dormant demand under this specific commodity designation.